In the in-depth exploration of exosomes by scientists worldwide, Creative Biolabs launches its innovative exosome analysis services, enhancing the understanding of these enigmatic extracellular vesicles.
Through a synergy of advanced techniques, including exosome lipidomics analysis, exosome next-generation sequencing (NGS), and precise exosome characterization, Creative Biolabs specializes in exosome research and development.
Exosomes have garnered remarkable attention for their immense potential in diagnostics, therapy, and targeted drug delivery. Delving into the molecular intricacies of these cellular messengers necessitates cutting-edge technology to unravel their genetic content, molecular makeup, and physical attributes. Creative Biolabs’ innovative services comprehensively meet these demands, unraveling comprehensive exosome-related solutions.
Exosome Lipidomics Analysis
Creative Biolabs’ exosome lipidomics analysis service empowers researchers to uncover the lipid composition of exosomes with unmatched accuracy. Given the critical influence of lipids on exosome biogenesis, cargo sorting, and structural integrity, Creative Biolabs employs spectrometry and chromatography methodologies to thoroughly scrutinize the lipidome of exosomes. This approach ensures not only dependable data but also reproducibility and expedited experimental cycles.
By harnessing the exosome NGS service from Creative Biolabs, researchers gain unprecedented access to the genetic essence of exosomes. Laden with diverse nucleic acids, particularly RNA, exosomes harbor substantial promise as sources of biomarkers and therapeutic agents. Leveraging sophisticated NGS platforms coupled with intricate bioinformatics analyses, Creative Biolabs offers exhaustive sequencing of exosomal RNA, encompassing:
- Exosome small RNA/miRNA sequencing
- Exosome mRNA sequencing
- Exosome mRNA microarray
- Exosome whole transcriptome sequencing
Accurate exosome size measurement is crucial for deciphering their functional implications and potential utilities. Creative Biolabs employs tunable resistive pulse sensing (TRPS) technology for exosome size quantification. This state-of-the-art methodology facilitates real-time, precise measurements of exosome size distribution, thereby ensuring the utmost accuracy of experimental findings.
This service features intricate details of exosome size disparities, enriching comprehension of these vesicles’ roles in physiological and pathological contexts. Furthermore, the exosome characterization offered by Creative Biolabs extends to nanoparticle tracking analysis, exosome surface labeling, and other advanced techniques.
“Creative Biolabs offers an all-in-one platform for exosome research and development. From exosome sampling to manufacturing, our expertise and technological prowess fulfill global clients’ experimental requisites,” affirmed Creative Biolabs’ scientists.
For more information about Creative Biolabs’ exosome analysis services, please visit https://www.creative-biolabs.com/exosome/.
About Creative Biolabs
Creative Biolabs, as a leading provider in the realm of biotechnology, offers an expansive spectrum of advanced services and solutions. In the latter half of the year, Creative Biolabs is set to participate in prestigious global life science gatherings, such as the 5th Exosome Based Therapeutic Development Summit and BioJapan 2023, spotlighting their wealth of experience and their top-tier scientific brigade.